Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020)
Neurocrine Biosciences (NBIX) posted Change in Working Capital of $4.1 million for Q1 2020, up 224.24% on a QoQ basis from -$3.3 million in Q1 2019, and up 224.24% year-over-year from $1.3 million in Q2 2019.
Neurocrine Biosciences (NBIX) Change in Working Capital (2019 - 2020) Analysis & Trends
Neurocrine Biosciences' Change in Working Capital history runs 2 years deep, the most recent figure standing at $4.1 million for Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -617.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2020 | 4.10 Mn |
| Mar 31, 2019 | -3.30 Mn |
| Mar 31, 2019 | -3.30 Mn |